Fees and payments
The TGA must take fees and charges to recover the cost of all activities that fall within the scope of the Therapeutic Goods Act 1989.
The TGA is required to recover its costs for all activities that fall within the scope of the Therapeutic Goods Act 1989, including the TGA's public health responsibilities.
- A fee is charged for a service, such as a product evaluation.
- A charge is a form of tax on regulated industry and is applied annually based on a 1 July to 30 June financial year.
Each year we consult with industry representative bodies in relation to proposed changes to fees and charges and publish a Cost Recovery Implementation Statement (CRIS). The CRIS provides information on how the TGA implements cost recovery activities associated with the registration and listing of medicines and inclusion of medical devices, including IVD devices, and biologicals onto the ARTG and the ongoing monitoring and surveillance of them.
More information
- Information & notices about TGA fees & payments
Information and notices about TGA fees and payments - Cost recovery implementation statements
The TGA routinely prepares cost recovery implementation statements - Forms (fees and payments)
Sponsor account and activity related forms - Annual Charge Exemption (ACE) scheme
The ACE scheme allows for the exemption of annual charges until a product first generates turnover - Request to cancel an ARTG entry
Cancel ARTG entries before 30 June to avoid next year's annual charges
Contact details
Invoice and payment enquiries
If your enquiry is not specifically about payments & invoices, see: Contact the TGA
|
General Enquiries: accountsrec@health.gov.au Remittance Advices: TGARemittanceAdvices@health.gov.au |
|
| Phone |
1800 020 653 (option 5) Users who are deaf or have a hearing or speech impairment can call through the National Relay Service:
|
| Postal address | TGA Revenue Management Regulatory Engagement Branch Therapeutic Goods Administration PO Box 100 Woden ACT 2606 Australia |
Latest articles
-
Sponsors and manufacturers reminded about upcoming financial deadlines
A reminder about financial deadlines that are approaching for sponsors and manufacturers.
Latest publications
-
This Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
This Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities.
-
This Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities